Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899008712> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2899008712 endingPage "123" @default.
- W2899008712 startingPage "114" @default.
- W2899008712 abstract "The object of the present study was to assess the Highly Active Antiretroviral therapy (HAART) regimens prescribed in study subjects attending Government General Hospital, Vijayawada, A.P, India, during April, 2012 to April, 2015. It was the cross-sectional record-based study. Out of 95 HIV infected children recruited for the study, 24 subjects were in pre-HAART era without taking antiretroviral drugs because they have shown CD4 count more than 350 cells/cmm, 60 subjects were in HAART era taking antiretroviral drugs because they have CD4 counts less than 350 cells/cmm and 11 subjects were mortal cases. Out of 60 subjects in HAART era, 29 (4.75%) subjects were on first-line treatment i.e., Stavudine + Lamivudine + Navirapine (SLN) regimen, 19 (32.0%) subjects were on Stavudine + Lamivudine + Efavirenz (SLE) regimen, 7 (12.0%) subjects were on Zidovudine + Lamivudine + Efavirenz (ZLE) regimen, 4 (6.5%) subjects were on Zidovudine + Lamivudine + Navirapine (ZLN) regimen, and only one subject (2.0%) was on Tenofovir containing regimen i.e., Tenofovir Disoproxil Fumarate + Emitricitabine + Efavirenz (TTE) second-line HAART regimen due to severe drug reaction to Zidovudine, Stavudine and Lamivudine containing regimens. 38.0% of male and 23.0% female subjects on SLE regimen were with mean age of 15.1 years, 9.0% of male and 15.0% of female subjects on ZLE regimen were with mean age of 15.5 years, 44.0% of male and 54.0% of female subjects on SLN regimen were with mean age of 15.2 years, 9.0% of male and 4.0% of female subjects on ZLN regimen with mean age of 17.5 years, and one (4%) female subject on TEE regimen with the age of 20 years. On the whole, the majority of the subjects under HAART shown rise in CD4 counts during the course of treatment indicating that regular therapy to HIV infected subjects prolong their life span." @default.
- W2899008712 created "2018-11-09" @default.
- W2899008712 creator A5014319700 @default.
- W2899008712 creator A5015384211 @default.
- W2899008712 creator A5050078527 @default.
- W2899008712 creator A5088109178 @default.
- W2899008712 date "2018-10-23" @default.
- W2899008712 modified "2023-09-24" @default.
- W2899008712 title "HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) REGIMENS PRESCRIBED IN STUDY SUBJECTS ATTENDING GOVERNMENT GENERAL HOSPITAL, VIJAYAWADA, ANDHRA PRADESH, INDIA" @default.
- W2899008712 hasPublicationYear "2018" @default.
- W2899008712 type Work @default.
- W2899008712 sameAs 2899008712 @default.
- W2899008712 citedByCount "0" @default.
- W2899008712 crossrefType "journal-article" @default.
- W2899008712 hasAuthorship W2899008712A5014319700 @default.
- W2899008712 hasAuthorship W2899008712A5015384211 @default.
- W2899008712 hasAuthorship W2899008712A5050078527 @default.
- W2899008712 hasAuthorship W2899008712A5088109178 @default.
- W2899008712 hasConcept C126322002 @default.
- W2899008712 hasConcept C142462285 @default.
- W2899008712 hasConcept C203014093 @default.
- W2899008712 hasConcept C2522874641 @default.
- W2899008712 hasConcept C2777869810 @default.
- W2899008712 hasConcept C2779889181 @default.
- W2899008712 hasConcept C2780216070 @default.
- W2899008712 hasConcept C2780593183 @default.
- W2899008712 hasConcept C2780727368 @default.
- W2899008712 hasConcept C2781413609 @default.
- W2899008712 hasConcept C2781432083 @default.
- W2899008712 hasConcept C2993143319 @default.
- W2899008712 hasConcept C3013748606 @default.
- W2899008712 hasConcept C71924100 @default.
- W2899008712 hasConceptScore W2899008712C126322002 @default.
- W2899008712 hasConceptScore W2899008712C142462285 @default.
- W2899008712 hasConceptScore W2899008712C203014093 @default.
- W2899008712 hasConceptScore W2899008712C2522874641 @default.
- W2899008712 hasConceptScore W2899008712C2777869810 @default.
- W2899008712 hasConceptScore W2899008712C2779889181 @default.
- W2899008712 hasConceptScore W2899008712C2780216070 @default.
- W2899008712 hasConceptScore W2899008712C2780593183 @default.
- W2899008712 hasConceptScore W2899008712C2780727368 @default.
- W2899008712 hasConceptScore W2899008712C2781413609 @default.
- W2899008712 hasConceptScore W2899008712C2781432083 @default.
- W2899008712 hasConceptScore W2899008712C2993143319 @default.
- W2899008712 hasConceptScore W2899008712C3013748606 @default.
- W2899008712 hasConceptScore W2899008712C71924100 @default.
- W2899008712 hasLocation W28990087121 @default.
- W2899008712 hasOpenAccess W2899008712 @default.
- W2899008712 hasPrimaryLocation W28990087121 @default.
- W2899008712 hasRelatedWork W1487496673 @default.
- W2899008712 hasRelatedWork W1893469951 @default.
- W2899008712 hasRelatedWork W2042504406 @default.
- W2899008712 hasRelatedWork W2068717533 @default.
- W2899008712 hasRelatedWork W2078674918 @default.
- W2899008712 hasRelatedWork W2170680962 @default.
- W2899008712 hasRelatedWork W2181389918 @default.
- W2899008712 hasRelatedWork W2268310984 @default.
- W2899008712 hasRelatedWork W2289323867 @default.
- W2899008712 hasRelatedWork W2318669600 @default.
- W2899008712 hasRelatedWork W2410152474 @default.
- W2899008712 hasRelatedWork W2610911222 @default.
- W2899008712 hasRelatedWork W2614988137 @default.
- W2899008712 hasRelatedWork W2768628185 @default.
- W2899008712 hasRelatedWork W2924437107 @default.
- W2899008712 hasRelatedWork W3030460364 @default.
- W2899008712 hasRelatedWork W3148053361 @default.
- W2899008712 hasRelatedWork W364611706 @default.
- W2899008712 hasRelatedWork W2586028565 @default.
- W2899008712 hasRelatedWork W2710825979 @default.
- W2899008712 isParatext "false" @default.
- W2899008712 isRetracted "false" @default.
- W2899008712 magId "2899008712" @default.
- W2899008712 workType "article" @default.